Scientific Sessions 2025  /  TCT at AHA: Renal Denervation for Hypertension: What Comes Next?  /  Debate Pro: RDN Could Be Useful for the Majority of Patients with Uncontrolled HTN
Logo

American Heart Association

  46
  0

Final ID:

Debate Pro: RDN Could Be Useful for the Majority of Patients with Uncontrolled HTN

  • Mahfoud, Felix  ( University Hospital Basel , Basel , Switzerland )
    • Author Disclosures:
    Felix Mahfoud: DO have relevant financial relationships ; Consultant:Ablative Solutions, Medtronic and ReCor Medical.:Past (completed) ; Speaker:Ablative Solutions, Astra-Zeneca, Inari, Medtronic, Merck, Novartis, Philips and ReCor Medical.:Past (completed) ; Researcher:Ablative Solutions, Medtronic and ReCor Medical.:Past (completed)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

TCT at AHA: Renal Denervation for Hypertension: What Comes Next?

Monday, 11/10/2025 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
Ultrasound Renal Denervation in Hypertension – From Paradise to TIVUS

Kirtane Ajay, Bloch Michael

Debate Con: Predictors of Efficacy are Sorely Needed in the RDN Space!

Cohen Debbie

More abstracts from these authors:
National Estimates of Patient Eligibility for Renal Denervation Therapy Post-FDA Approval

Watson Nathan, Earle William, Kandzari David, Kirtane Ajay, Mahfoud Felix, Cluett Jennifer, Krawisz Anna, Juraschek Stephen, Secemsky Eric

Alternative Renal Denervation Devices – From Ablative Solutions to Verve

Kandzari David, Kirtane Ajay, Mahfoud Felix

You have to be authorized to contact abstract author. Please, Login
Not Available